tiprankstipranks
Trending News
More News >
TransMedics Group Inc (TMDX)
NASDAQ:TMDX
US Market
Advertisement

TransMedics Group (TMDX) Ratios

Compare
1,567 Followers

TransMedics Group Ratios

TMDX's free cash flow for Q2 2025 was $0.61. For the 2025 fiscal year, TMDX's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
9.86 9.30 10.66 5.11 12.36
Quick Ratio
9.17 8.49 9.79 4.47 11.35
Cash Ratio
7.07 7.19 8.50 1.10 2.07
Solvency Ratio
0.16 -0.03 -0.36 -0.62 -0.56
Operating Cash Flow Ratio
2.04 -0.24 -1.94 -1.24 -2.55
Short-Term Operating Cash Flow Coverage
38.16 0.00 -31.73 0.00 0.00
Net Current Asset Value
$ -14.29M$ -58.19M$ 162.52M$ 51.67M$ 98.63M
Leverage Ratios
Debt-to-Assets Ratio
0.52 0.73 0.24 0.06 0.23
Debt-to-Equity Ratio
1.44 3.76 0.36 0.13 0.33
Debt-to-Capital Ratio
0.59 0.79 0.26 0.11 0.25
Long-Term Debt-to-Capital Ratio
0.59 0.79 0.24 0.34 0.25
Financial Leverage Ratio
2.80 5.15 1.48 1.99 1.46
Debt Service Coverage Ratio
10.03 -0.55 -5.61 -9.94 -5.82
Interest Coverage Ratio
10.68 -2.66 -8.44 -10.18 -6.62
Debt to Market Cap
0.11 0.20 0.03 0.07 0.07
Interest Debt Per Share
13.75 16.20 2.41 0.45 1.56
Net Debt to EBITDA
0.58 -15.93 4.61 0.44 -0.44
Profitability Margins
Gross Profit Margin
59.79%63.77%69.84%69.92%64.88%
EBIT Margin
8.40%-6.57%-34.71%-133.19%-96.46%
EBITDA Margin
19.22%-3.15%-30.99%-127.18%-90.31%
Operating Profit Margin
14.41%-11.89%-33.64%-130.29%-102.91%
Pretax Profit Margin
13.95%-11.04%-38.70%-145.99%-112.00%
Net Profit Margin
13.49%-10.36%-38.77%-146.11%-112.13%
Continuous Operations Profit Margin
6.92%-10.36%-38.77%-146.11%-112.13%
Net Income Per EBT
96.72%93.84%100.18%100.08%100.11%
EBT Per EBIT
96.75%92.84%115.04%112.05%108.84%
Return on Assets (ROA)
8.05%-3.54%-13.07%-32.78%-18.91%
Return on Equity (ROE)
28.02%-18.24%-19.34%-65.16%-27.67%
Return on Capital Employed (ROCE)
9.18%-4.41%-12.40%-35.31%-18.83%
Return on Invested Capital (ROIC)
9.16%-4.13%-12.28%-35.34%-18.85%
Return on Tangible Assets
8.17%-3.62%-13.07%-32.78%-18.91%
Earnings Yield
1.68%-0.98%-1.99%-8.36%-5.85%
Efficiency Ratios
Receivables Turnover
5.07 3.80 3.38 5.10 3.74
Payables Turnover
22.39 6.88 8.44 1.37 7.47
Inventory Turnover
5.50 1.98 1.37 0.61 0.75
Fixed Asset Turnover
1.67 1.34 3.84 1.93 5.39
Asset Turnover
0.60 0.34 0.34 0.22 0.17
Working Capital Turnover Ratio
1.12 0.71 0.58 0.26 0.23
Cash Conversion Cycle
122.15 227.47 331.39 400.69 532.60
Days of Sales Outstanding
72.03 96.04 107.83 71.57 97.72
Days of Inventory Outstanding
66.41 184.46 266.82 595.80 483.77
Days of Payables Outstanding
16.30 53.03 43.26 266.68 48.89
Operating Cycle
138.45 280.50 374.65 667.37 581.49
Cash Flow Ratios
Operating Cash Flow Per Share
3.40 -0.40 -1.55 -1.05 -1.23
Free Cash Flow Per Share
0.51 -5.91 -1.95 -1.17 -1.24
CapEx Per Share
2.89 5.51 0.40 0.13 0.02
Free Cash Flow to Operating Cash Flow
0.15 14.74 1.26 1.12 1.02
Dividend Paid and CapEx Coverage Ratio
1.18 -0.07 -3.85 -8.20 -66.52
Capital Expenditure Coverage Ratio
1.18 -0.07 -3.85 -8.20 -66.52
Operating Cash Flow Coverage Ratio
0.25 -0.03 -0.68 -3.35 -0.87
Operating Cash Flow to Sales Ratio
0.22 -0.05 -0.49 -0.95 -1.18
Free Cash Flow Yield
0.40%-7.48%-3.16%-6.12%-6.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
59.50 -102.55 -50.35 -11.97 -17.10
Price-to-Sales (P/S) Ratio
8.07 10.62 19.52 17.49 19.17
Price-to-Book (P/B) Ratio
13.41 18.71 9.74 7.80 4.73
Price-to-Free Cash Flow (P/FCF) Ratio
247.03 -13.36 -31.60 -16.34 -16.00
Price-to-Operating Cash Flow Ratio
36.99 -197.01 -39.82 -18.33 -16.24
Price-to-Earnings Growth (PEG) Ratio
1.32 2.74 2.18 -0.32 0.34
Price-to-Fair Value
13.41 18.71 9.74 7.80 4.73
Enterprise Value Multiple
42.55 -353.51 -58.38 -13.31 -21.67
Enterprise Value
4.35B 2.69B 1.69B 512.16M 501.66M
EV to EBITDA
42.55 -353.51 -58.38 -13.31 -21.67
EV to Sales
8.18 11.12 18.09 16.92 19.57
EV to Free Cash Flow
250.42 -13.99 -29.29 -15.82 -16.33
EV to Operating Cash Flow
37.69 -206.30 -36.90 -17.74 -16.58
Tangible Book Value Per Share
8.98 3.78 6.34 2.46 4.21
Shareholders’ Equity Per Share
9.38 4.22 6.34 2.46 4.21
Tax and Other Ratios
Effective Tax Rate
>-0.01 0.06 >-0.01 >-0.01 >-0.01
Revenue Per Share
15.67 7.43 3.16 1.10 1.04
Net Income Per Share
2.11 -0.77 -1.23 -1.60 -1.16
Tax Burden
0.97 0.94 1.00 1.00 1.00
Interest Burden
1.66 1.68 1.11 1.10 1.16
Research & Development to Revenue
0.12 0.26 0.29 0.74 0.73
SG&A to Revenue
0.17 0.49 0.55 1.27 0.94
Stock-Based Compensation to Revenue
0.07 0.08 0.11 0.23 0.09
Income Quality
1.61 0.52 1.26 0.65 1.05
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis